A carregar...
Anti-IL-5 Biologicals Targeting Severe Late Onset Eosinophilic Asthma
Improved knowledge about the pathogenesis of asthma has facilitated the development of novel drugs and provided hope for patients with severe asthma. After the short- and long-term success of omalizumab in severe allergic phenotype, researchers have targeted patients with severe eosinophilic asthma...
Na minha lista:
| Publicado no: | Turk Thorac J |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Turkish Thoracic Society
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7020889/ https://ncbi.nlm.nih.gov/pubmed/32163366 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/TurkThoracJ.2019.180204 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|